Lymphovascular invasion as a prognostic indicator in stage i non-small cell lung cancer: A systematic review and meta-analysis

Annals of Thoracic Surgery

Volumn 97, Issue 3, 2014, Pages 965-971

  Mollberg, Nathan M ^a   Bennette, Carrie ^b   Howell, Eric ^a   Backhus, Leah ^a   Devine, Beth ^b   Ferguson, Mark K ^c  

^a UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER PROGNOSIS; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; HISTOLOGY; HUMAN; LUNG NON SMALL CELL CANCER; LYMPH VESSEL METASTASIS; META ANALYSIS; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; QUALITY CONTROL; RECURRENCE FREE SURVIVAL; REVIEW; SENSITIVITY ANALYSIS; SURVIVAL PREDICTION; SYSTEMATIC REVIEW;

CARCINOMA, NON-SMALL-CELL LUNG; HUMANS; LUNG NEOPLASMS; LYMPH NODES; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROGNOSIS; PROSPECTIVE STUDIES; VASCULAR NEOPLASMS;

EID: 84896695211     PISSN: 00034975     EISSN: 15526259     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2013.11.002     Document Type: Article

References (36)

1. P.A. Groome, V. Bolejack, and J.J. Crowley et al. The IASLC Lung Cancer Staging Project: validation of the proposals for revision of the T, N, and M descriptors and consequent stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours J Thorac Oncol 2 2007 694 705
2. International Early Lung Cancer Action Program Investigators, C.I. Henschke, D.F. Yankelevitz, and D.M. Libby et al. Survival of patients with stage I lung cancer detected on CT screening N Engl J Med 355 2006 1763 1771
3. Z. Li, Y. Yu, and J. Lu et al. Analysis of the T descriptors and other prognosis factors in pathologic stage I non-small cell lung cancer in China J Thorac Oncol 4 2009 702 709
4. H. Han, J.F. Silverman, and T.S. Santucci et al. Vascular endothelial growth factor expression in stage I non-small cell lung cancer correlates with neoangiogenesis and a poor prognosis Ann Surg Oncol 8 2001 72 79
5. C.P. Hsu, J.Y. Hsia, and G.C. Chang et al. Surgical-pathologic factors affect long-term outcomes in stage IB (pT2 N0 M0) non-small cell lung cancer: a heterogeneous disease J Thorac Cardiovasc Surg 138 2009 426 433
6. T. Kato, K. Ishikawa, and M. Aragaki et al. Angiolymphatic invasion exerts a strong impact on surgical outcomes for stage I lung adenocarcinoma, but not non-adenocarcinoma Lung Cancer 77 2012 394 400
7. Q. Lin, M. Li, and Z.Y. Shen et al. Prognostic impact of vascular endothelial growth factor-A and E-cadherin expression in completely resected pathologic stage I non-small cell lung cancer Jpn J Clin Oncol 40 2010 670 676
8. C. Liu, J. Liu, and X. Wang et al. Prognostic impact of nm23-H1 and PCNA expression in pathologic stage I non-small cell lung cancer J Surg Oncol 104 2011 181 186
9. R. Maeda, J. Yoshida, and G. Ishii et al. Long-term survival and risk factors for recurrence in stage I non-small cell lung cancer patients with tumors up to 3 cm in maximum dimension Chest 138 2010 357 362
10. M.J. Schuchert, L. Schumacher, and A. Kilic et al. Impact of angiolymphatic and pleural invasion on surgical outcomes for stage I non-small cell lung cancer Ann Thorac Surg 91 2011 1059 1065
11. J. Wang, B. Wang, and W. Zhao et al. Clinical significance and role of lymphatic vessel invasion as a major prognostic implication in non-small cell lung cancer: a meta-analysis PLoS One 7 2012 e52704
12. J. Wang, J. Chen, and X. Chen et al. Blood vessel invasion as a strong independent prognostic indicator in non-small cell lung cancer: a systematic review and meta-analysis PLoS One 6 2011 e28844
13. E. Steels, M. Paesmans, and T. Berghmans et al. Role of p53 as a prognostic factor for survival in lung cancer: a systematic review of the literature with a meta-analysis Eur Respir J 18 2001 705 719
14. R. DerSimonian, and N. Laird Meta-analysis in clinical trials Control Clin Trials 7 1986 177 187
15. H. Igai, N. Matsuura, and S. Tarumi et al. Prognostic factors in patients after lobectomy for p-T1aN0M0 adenocarcinoma Eur J Cardiothorac Surg 41 2012 603 606
16. J.M. Varlotto, A. Recht, and J.C. Flickinger et al. Varying recurrence rates and risk factors associated with different definitions of local recurrence in patients with surgically resected, stage I nonsmall cell lung cancer Cancer 116 2010 2390 2400
17. K. Miyoshi, S. Moriyama, T. Kunitomo, and S. Nawa Prognostic impact of intratumoral vessel invasion in completely resected pathologic stage I non-small cell lung cancer J Thorac Cardiovasc Surg 137 2009 429 434
18. E. Ruffini, S. Asioli, and P.L. Filosso et al. Significance of the presence of microscopic vascular invasion after complete resection of stage I-II pT1-T2N0 non-small cell lung cancer and its relation with T-size categories: did the 2009 7th edition of the TNM staging system miss something? J Thorac Oncol 6 2011 319 326
19. M.K. Parmar, V. Torri, and L. Stewart Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints Stat Med 17 1998 2815 2834
20. M. Egger, G.D. Smith, M. Schneider, and C. Minder Bias in meta-analysis detected by a simple, graphical test BMJ 315 1997 629 634
21. R. Maeda, J. Yoshida, and G. Ishii et al. Risk factors for tumor recurrence in patients with early-stage (stage I and II) non-small cell lung cancer: patient selection criteria for adjuvant chemotherapy according to the seventh edition TNM classification Chest 140 2011 1494 1502
22. K. Minami, Y. Saito, H. Imamura, and A. Okamura Prognostic significance of p53, Ki-67, VEGF and Glut-1 in resected stage I adenocarcinoma of the lung Lung Cancer 38 2002 51 57
23. W. Shao, W. Wang, and X.G. Xiong et al. Prognostic impact of MMP-2 and MMP-9 expression in pathologic stage IA non-small cell lung cancer J Surg Oncol 104 2011 841 846
24. S. Shiono, M. Abiko, and T. Sato Positron emission tomography/computed tomography and lymphovascular invasion predict recurrence in stage I lung cancers J Thorac Oncol 6 2011 43 47
25. T. Tsuchiya, S. Akamine, and M. Muraoka et al. Stage IA non-small cell lung cancer: vessel invasion is a poor prognostic factor and a new target of adjuvant chemotherapy Lung Cancer 56 2007 341 348
26. D.C. Wei, Y.C. Yeh, and J.J. Hung et al. Overexpression of T-LAK cell-originated protein kinase predicts poor prognosis in patients with stage I lung adenocarcinoma Cancer Sci 103 2012 731 738
27. T. Woo, K. Okudela, and H. Mitsui et al. Prognostic value of the IASLC/ATS/ERS classification of lung adenocarcinoma in stage I disease of Japanese cases Pathol Int 62 2012 785 791
28. Z. Zhang, A. Wang, and Z. Zhan et al. T1aN0M0 and T1bN0M0 non-small cell lung cancer: a retrospective study of the prognosis Thorac Cardiovasc Surg 2012 Available at: http://dx.doi.org/10.1055/s-0032-1329191 Accessed January 9, 2014
29. H. Tao, T. Hayashi, F. Sano, A. Takahagi, T. Tanaka, E. Matsuda, and K. Okabe Prognostic impact of lymphovascular invasion compared with that of visceral pleural invasion in patients with pN0 non-small-cell lung cancer and a tumor diameter of 2 cm or smaller J Surg Res 185 2013 250 254
30. N. Yanagawa, S. Shiono, M. Abiko, S.Y. Ogata, T. Sato, and G. Tamura Prognostic impact and initial recurrence site of lymphovascular and visceral pleural invasion in surgically resected stage I non-small-cell lung carcinoma Eur J Cardiothorac Surg 44 2013 e200 e206
31. E.A. Rakha, S. Martin, and A.H. Lee et al. The prognostic significance of lymphovascular invasion in invasive breast carcinoma Cancer 118 2012 3670 3680
32. L. Cheng, T.D. Jones, and H. Lin et al. Lymphovascular invasion is an independent prognostic factor in prostatic adenocarcinoma J Urol 174 2005 2181 2185
33. S.B. Lim, C.S. Yu, and S.J. Jang et al. Prognostic significance of lymphovascular invasion in sporadic colorectal cancer Dis Colon Rectum 53 2010 377 384
34. G.G. Van den Eynden, I. Van der Auwera, and S.J. Van Laere et al. Distinguishing blood and lymph vessel invasion in breast cancer: a prospective immunohistochemical study Br J Cancer 94 2006 1643 1649
35. Y. Ichinose, T. Yano, and H. Asoh et al. Prognostic factors obtained by a pathologic examination in completely resected non-small cell lung cancer. An analysis in each pathologic stage J Thorac Cardiovasc Surg 110 1995 601 605
36. P.L. Wagner, A.C. Stiedl, and T. Wilbertz et al. Frequency and clinicopathologic correlates of KRAS amplification in non-small cell lung carcinoma Lung Cancer 74 2011 118 123